Wolverine Trading
SEEL

Wolverine Trading’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Wolverine Trading’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed -$10.5K – 5268
2022
Q3 		$14K Buy
+3
New +$11.8K ﹤0.01% 4417
2016
Q3 		– Hold
0
– -$11K – 5221
2016
Q2 		– Hold
0
– – – 3930

Other funds holding SEEL

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's SEEL Position: Q4 2022 in Review

Wolverine Trading sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2022, closing a stake of 3 shares — an estimated $10.5K sold.

Wolverine Trading first reported a position in SEEL in Q3 2022 and held it in 1 quarter. The position peaked at $14K in Q3 2022. 63 funds tracked by Wall St. Rank hold SEEL as of Q4 2022.

  • Wolverine Trading reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 3 Seelos Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $10.5K.
  • Wolverine Trading first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Wolverine Trading's Seelos Therapeutics, Inc. Common Stock position peaked at $14K in Q3 2022.
  • 63 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.